Mark Glickman

Mark Glickman

Directeur/Bestuurslid bij METAVIA INC.

Vermogen: 9 778 $ op 31-05-2026

60 jaar
Health Technology
Commercial Services
Consumer Services

Profiel

Mark A. Glickman is President & Chief Executive Officer at BioFlorida, Inc. since 2023.
He is Director at Otsuka Precision Health, Inc. starting in 2024.
He serves as Independent Director at MetaVia, Inc. since 2023 and at BioStem Technologies, Inc. beginning in 2026.
Formerly, Mr. Glickman was Co-CEO & Chief Business Officer at TherapeuticsMD, Inc. from 2022 to 2023.
He was Marketing Director & Vice President-Sales at KOS Pharmaceuticals, Inc. from 2001 to 2007.
He held the position of General Manager-Sales at Baxter Healthcare Corp.
from 1989 to 1995.
He served as Senior Vice President-Sales & Marketing at Oscient Pharmaceuticals Corp.
from 2007 to 2009.
He was Chief Commercial Officer at Esperion Therapeutics, Inc. from 2018 to 2020.
He held the role of Chief Commercial Officer at POZEN, Inc. from 2015 to 2016.
He was Senior Vice President-Sales at Auxilium Pharmaceuticals LLC from 2012 to 2015.
He was Vice President-Sales at Bayer HealthCare.
He served as Vice President-Medical Device Division at Otsuka America Pharmaceutical, Inc. from 2009 to 2012.
He was Chief Commercial Officer at Old API Wind-down Ltd. from 2015 to 2018.
Education includes undergraduate studies at State University of New York College at Oswego and an MBA from NYU Stern School of Business.

Bekende belangen in openbare bedrijven

OndernemingDatumAantal aandelenTotale waardeWaarderingsdatum
08-06-2026 3.443 ( 0,07% ) 9 778 $ 31-05-2026

Actieve functies van Mark Glickman

BedrijvenFunctieBegin
METAVIA INC. Directeur/Bestuurslid 11-05-2023
BIOSTEM TECHNOLOGIES, INC. Directeur/Bestuurslid 05-06-2026
Algemeen Directeur 09-12-2023

Eerdere bekende functies van Mark Glickman

BedrijvenFunctieEinde
THERAPEUTICSMD, INC. Algemeen Directeur 01-01-2023
ESPERION THERAPEUTICS, INC. Corporate Officer/Principal 11-12-2020
OLD API WIND-DOWN LTD. Corporate Officer/Principal 30-03-2018
POZEN INC. Corporate Officer/Principal 01-02-2016
AUXILIUM PHARMACEUTICALS, INC. Verkoop & Marketing 01-03-2015
Ervaring van Mark Glickman in detail bekijken

Opleiding van Mark Glickman

Ervaring
Beklede functies

Actief

Inactief

Beursgenoteerde bedrijven

Bedrijven in privébezit

Connecties

64

Eerstegraads connecties

14

Bedrijven verbonden in de eerste graad

Man

Vrouw

Besturend

Uitvoerend

Verwante bedrijven

Bedrijven in privébezit14

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Distribution Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

  1. Beurs
  2. Insiders
  3. Mark Glickman
DE LAATSTE UREN | -40 %: De beste tools voorbehouden aan abonnees om de beste beleggingen van morgen te identificeren!
d
:
:
PROFITEER NU